BusinessTechnology

Huntress Executive Counters Common MSP Misconceptions About Security Capabilities

A Huntress executive has publicly addressed several misconceptions that MSPs hold about the company’s cybersecurity offerings. The clarification covers topics ranging from Microsoft Defender integration to the maturity of their managed SIEM platform and the company’s independence from acquisition interests.

Addressing MSP Security Misconceptions

According to reports from the 2025 XChange NexGen conference in Houston, Huntress executives have taken direct aim at several misconceptions that managed service providers reportedly hold about the cybersecurity company. Sources indicate that Jeremy Young, Huntress’ community growth strategist, identified four specific myths during his presentation that he sought to dispel for the MSP community.

BusinessTrade

Nvidia CEO Warns of Mutual Harm in US-China Tech Restrictions as Company Loses Entire Chinese Market

Nvidia’s CEO has revealed the company has gone from 95% to 0% market share in China due to export restrictions. Jensen Huang warned that policies damaging China often harm America as well, emphasizing the importance of maintaining technological collaboration with Chinese AI researchers.

Nvidia CEO Expresses Concern Over US-China Trade Policies

Nvidia CEO Jensen Huang has voiced significant concerns about the ongoing trade restrictions between the United States and China, warning that policies harming China could negatively impact America as well. Speaking at the Citadel Securities Future of Global Markets 2025 conference, Huang revealed that Nvidia has lost its entire market share in China due to current export controls.

AIHealthcareStartups

Medical AI Startup OpenEvidence Secures $200M Funding at $6B Valuation

OpenEvidence, an AI platform compared to a medical version of ChatGPT, has reportedly secured $200 million in new funding. The company’s valuation has reached $6 billion as it expands its user base among doctors and medical practitioners.

Medical AI Platform Gains Momentum

OpenEvidence, an artificial intelligence company developing specialized tools for healthcare professionals, has reportedly raised $200 million in its latest funding round, according to sources familiar with the matter. The funding values the startup company at approximately $6 billion, demonstrating continued investor confidence in specialized AI applications despite broader market concerns about artificial intelligence sector overheating.